Structural Features Important for .sigma.1 Receptor Binding

Journal of Medicinal Chemistry
1994.0

Abstract

Two problems that have hampered sigma receptor research are (i) a lack of high-affinity agents and (ii) the recent identification of multiple populations of sigma receptors (i.e., sigma 1 and sigma 2 sites). Recently, several high-affinity sigma ligands have been identified, and the term superpotent sigma ligands has been coined to describe agents with Ki values of < 1 nM. We have previously shown that appropriately N-substituted phenylalkylamines bind at sigma receptors with high affinity. In the present investigation, we examine the structure-affinity relationships of these phenylalkylamine derivatives for sigma 1 binding and describe some of the first superpotent sigma 1 ligands. A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with sigma 1 sites.

Knowledge Graph

Similar Paper

Structural Features Important for .sigma.1 Receptor Binding
Journal of Medicinal Chemistry 1994.0
Identification and exploitation of the .sigma.-opiate pharmacophore
Journal of Medicinal Chemistry 1991.0
Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect
European Journal of Medicinal Chemistry 2022.0
Synthesis and binding characteristics of potential SPECT imaging agents for .sigma.-1 and .sigma.-2 binding sites
Journal of Medicinal Chemistry 1993.0
Novel Sigma Receptor Ligands:  Synthesis and Biological Profile
Journal of Medicinal Chemistry 2007.0
Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of σ1 ligands
European Journal of Medicinal Chemistry 2013.0
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site☆
European Journal of Medicinal Chemistry 2009.0
.sigma. Ligands with Subnanomolar Affinity and Preference for the .sigma.2 Binding Site. 1. 3-(.omega.-Aminoalkyl)-1H-indoles
Journal of Medicinal Chemistry 1995.0
A new approach to the design of .sigma.-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine-related polyamines at .sigma.-1 and .sigma.-2 receptor subtypes
Journal of Medicinal Chemistry 1994.0
(+)-cis-N-Ethyleneamino-N-normetazocine Derivatives. Novel and Selective σ Ligands with Antagonist Properties
Journal of Medicinal Chemistry 1998.0